Arog Pharmaceuticals
PrivateLast Round
IPO
Sep 28, 2018
Company Overview
Arog Pharmaceuticals is a biopharmaceutical company that develops small molecule kinase inhibitors for the treatment of cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Arog Pharmaceuticals Comparables
Compare Arog Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Hanmi Pharm Co Ltd | 81% | |
| Crescent Biopharma | 77% | |
| Astellas Pharma Inc. | 75% | |
Arog Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| IPO | Sep 28, 2018 |
Key People
Founding team and executive leadership
Arog Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Nomura Securities | IPO |
| RBC Capital Markets | IPO |
| Citigroup | IPO |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 19, 2025
Grew 50% QoQ from 8 to 12 employees.
Arog Pharmaceuticals Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Arog Pharmaceuticals's valuation, stock price, and market status.